TP53INP2-dependent activation of muscle autophagy ameliorates sarcopenia and promotes healthy aging
Serious side effects Tirzepatide can cause serious side effects
Microbiome support is not a replacement for medical therapy, but it may complement the conditions involved in natural GLP-1 support and healthy metabolic function
The comparison between these two GLP-1 medications reveals some interesting differences
Choquette AC, Bouchard L, Drapeau V, Lemieux S, Tremblay A, Bouchard C, Vohl MC, Perusse L
Participants were randomly assigned in a 2:1:1:1:1:2:2 ratio to receive subcutaneous retatrutide (1 mg, 4 mg [initial dose, 2 mg], 4 mg [initial dose, 4 mg], 8 mg [initial dose, 2 mg], 8 mg [initial dose, 4 mg], or 12 mg [initial dose, 2 mg]) or placebo once weekly for 48 weeks